迪安诊断跌2.04%，成交额1.71亿元，主力资金净流出1640.86万元

Core Viewpoint - The stock price of Dian Diagnostics has shown a year-to-date increase of 38.48%, but has recently experienced a decline of 3.51% over the past five trading days and 13.55% over the past twenty days [2] Financial Performance - As of June 30, Dian Diagnostics reported a revenue of 4.936 billion yuan, representing a year-on-year decrease of 20.61%, and a net profit attributable to shareholders of 10.2772 million yuan, down 85.68% year-on-year [2] - The company has distributed a total of 1.099 billion yuan in dividends since its A-share listing, with 712 million yuan distributed over the past three years [3] Stock Market Activity - On October 14, the stock price fell by 2.04%, trading at 15.38 yuan per share with a total transaction volume of 171 million yuan and a turnover rate of 2.18%, resulting in a total market capitalization of 9.612 billion yuan [1] - The net outflow of main funds was 16.4086 million yuan, with large orders showing a buy of 28.2954 million yuan and a sell of 40.5438 million yuan [1] Shareholder Structure - As of June 30, 2025, the number of shareholders decreased by 11.32% to 48,300, with an average of 10,376 circulating shares per person, an increase of 12.77% [2] - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 14.7985 million shares, an increase of 3.4713 million shares from the previous period [3]